Does drug treatment of Alzheimer 's disease patients lead to expression changes in peripheral blood cells?
Distinct separation between non-treated, galantamine, donepezil, and rivastigmine-treated patients was clearly identified based on small sets of expression probes. The ability to identify drug-specific treatment expression differences strengthens the potential for using peripheral gene signatures for the identification of individuals responding to drug treatment.
Basketball players experienced a progressive deterioration in performance as DEH progressed from 1 to 4%. The threshold, or % DEH at which the performance decrement reached statistical significance, was 2% for combined timed and shooting drills.